Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
von M?ssenhausen A, Deng M, Billig H, Queisser A, Vogel W, Kristiansen G, Schr?ck A, Bootz F, G?ke F, Franzen A, Heasley L, Kirfel J, Br?gelmann J, Perner S. Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma. Target Oncol. 2016 10; 11(5):631-642.